FDA approves alcoholism treatment
Two companies, Alkermes and Cephalon, get FDA green light for alcoholism treatment Vivitrol.
NEW YORK (CNNMoney.com staff writer) - The Food and Drug Administration approved Vivitrol, a treatment for alcoholism from two companies, Alkermes and Cephalon, the drug companies said.
Vivitrol is meant to reduce the craving for alcohol and is injected once a month into alcoholics who are trying to quit drinking.
Cephalon (up $0.48 to $60.20, Research) and Alkermes (up $0.89 to $21.96, Research) said the drug should be available in June 2006. Alkermes is responsible for making the drug and Cephalon has primary responsibility for marketing and sales.
To read projections for more drug stocks, click here.